The vaccine candidate “triggered strong immune response amongst adults of all age groups,” the companies said in a joint statement.
Sanofi, GSK expect to seek vaccine authorization in late 2021
The vaccine candidate “triggered strong immune response amongst adults of all age groups,” the companies said in a joint statement.